Literature DB >> 16414441

Impact of convective flow on phosphorus removal in maintenance hemodialysis patients.

Willy Lornoy1, Johan De Meester, Ignace Becaus, Jean-Marie Billiouw, Paul A Van Malderen, Mia Van Pottelberge.   

Abstract

OBJECTIVE: Hyperphosphatemia leads to increased risk of death in maintenance hemodialysis patients (MHD). This study investigated phosphorus (P) removal, P reduction rate (PRR), and P rebound, comparing on-line, high-volume hemodiafiltration in postdilution (HDF) and high-flux hemodialysis (HD) in a setting of an equal amount of produced dialysate solution in both modalities.
METHODS: A total of 22 MHD patients, treated with regular 3 x 4 hours HDF weekly, were randomly dialyzed with one 4-hour session of HDF and of HD. In both modalities, an equal amount of produced dialysate solution of 800 mL/minute was used. The only variable was the fact that in HDF, 100 mL/min of this produced dialysate solution was used as replacement fluid. The other parameters were kept identical: blood flow rate, 350 mL/min; high-flux polysulfone F80 dialyzer; and 4800 E monitor, (Fresenius, Bad Homburg, Germany). The P removal was measured in total spent dialysate and ultrafiltrate volumes. Statistical analyses were done with the paired t-test.
RESULTS: The mean total P removed with HDF was 1159 +/- 296 mg, and 972 +/- 312 mg with HD (P < .001), ie, 19% higher in HDF; PRR was significantly higher in HDF (63.3%) versus HD (58.6%) (P = .014). The mean serum P did not differ: 5.3 mg/dL in HDF and 5.2 mg/dL in HD. There was a linear correlation between serum P and P removal. With a serum P level up to 5 to 5.5 mg/dL, HDF achieved a higher P removal compared with HD. The difference gradually decreased as the serum P value increased. Above 7 mg/dL, no difference in total P removal was observed. There was a high but equal rebound percentage at 60 minutes in HDF (42%) and HD (39%) (P = .42). With HDF, no predialysis metabolic acidosis was noted.
CONCLUSIONS: Treatment with on-line HDF in postdilution resulted in a higher P removal and higher PRR compared with HD. The long-term implementation of this modality may result in a more optimal serum P control, without an increase in the number of or lengthening of the dialysis sessions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16414441     DOI: 10.1053/j.jrn.2005.10.008

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  12 in total

1.  Hemodiafiltration to Address Unmet Medical Needs ESKD Patients.

Authors:  Bernard Canaud; Jörg Vienken; Stephen Ash; Richard A Ward
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-06       Impact factor: 8.237

Review 2.  Hemodiafiltration: the addition of convective flow to hemodialysis.

Authors:  Michel Fischbach; Helen Fothergill; Arianne Zaloszyc; Laure Seuge
Journal:  Pediatr Nephrol       Date:  2011-02-06       Impact factor: 3.714

3.  Effects of high-efficiency postdilution online hemodiafiltration and high-flux hemodialysis on serum phosphorus and cardiac structure and function in patients with end-stage renal disease.

Authors:  Rodríguez Castellanos Francisco; Meave Aloha; Paniagua Sierra Ramón
Journal:  Int Urol Nephrol       Date:  2012-11-10       Impact factor: 2.370

4.  Effects of the Use of Non-Calcium Phosphate Binders in the Control and Outcome of Vascular Calcifications: A Review of Clinical Trials on CKD Patients.

Authors:  Piergiorgio Bolasco
Journal:  Int J Nephrol       Date:  2011-06-09

5.  Online-haemodiafiltration vs. conventional haemodialysis: a cross-over study.

Authors:  Guillaume Jean; Jean-Marc Hurot; Patrik Deleaval; Brice Mayor; Christie Lorriaux
Journal:  BMC Nephrol       Date:  2015-05-09       Impact factor: 2.388

6.  Online hemodiafilteration use in children: a single center experience with a twist.

Authors:  Magid A A Ibrahim; Ihab Z ElHakim; Dina Soliman; Muhammad A Mubarak; Ragia M Said
Journal:  BMC Nephrol       Date:  2020-07-28       Impact factor: 2.388

7.  Interventional study to improve adherence to phosphate binder treatment in dialysis patients.

Authors:  Bodil Jahren Hjemås; Katrine Bøvre; Liv Mathiesen; Jonas Christoffer Lindstrøm; Kathrin Bjerknes
Journal:  BMC Nephrol       Date:  2019-05-17       Impact factor: 2.388

8.  HDF promise for the future.

Authors:  Willy Lornoy; Johan De Meester
Journal:  Nephrol Dial Transplant       Date:  2008-05-21       Impact factor: 5.992

Review 9.  Phosphate control in dialysis.

Authors:  Adamasco Cupisti; Maurizio Gallieni; Maria Antonietta Rizzo; Stefania Caria; Mario Meola; Piergiorgio Bolasco
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-10-04

10.  High-Flux Hemodialysis and High-Volume Hemodiafiltration Improve Serum Calcification Propensity.

Authors:  Marijke Dekker; Andreas Pasch; Frank van der Sande; Constantijn Konings; Matthias Bachtler; Mauro Dionisi; Matthias Meier; Jeroen Kooman; Bernard Canaud
Journal:  PLoS One       Date:  2016-04-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.